Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Urged To Create Codes For Continuous Glucose Monitoring Devices

This article was originally published in The Gray Sheet

Executive Summary

CMS should make a proactive decision to put durable medical equipment codes in place for continuous glucose monitoring, urged manufacturers April 25

You may also be interested in...



CMS Proposes Unique Codes For Continuous Glucose Monitoring

CMS is proposing to establish unique codes for continuous glucose monitors, a decision that could help manufacturers secure reimbursement from both Medicare and private payors

CMS Proposes Unique Codes For Continuous Glucose Monitoring

CMS is proposing to establish unique codes for continuous glucose monitors, a decision that could help manufacturers secure reimbursement from both Medicare and private payors

CMS denies new CGM code

CMS shoots down Dexcom and Medtronic requests for continuous glucose monitors (CGM) to get their own HCPCS codes, notwithstanding congressional pressure. In March, CMS tentatively denied the companies' requests to establish three new codes to describe the components of CGM. In August, a Medicare Coverage and Advisory Committee advised CMS that the technology has not been proved superior to traditional monitoring. Although Medicare does not cover CGM, securing codes for the technology would aid in establishing reimbursement from other public and private payors (1"The Gray Sheet" May 1, 2006, p. 8)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel